ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Est. Return 169.78%
This Quarter Est. Return
1 Year Est. Return
+169.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$86.2M
AUM Growth
-$13.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
46
New
Increased
Reduced
Closed

Top Buys

1
+$4.8M
2
+$2.78M
3
+$2.38M
4
MRK icon
Merck
MRK
+$2.06M
5
SRZN icon
Surrozen
SRZN
+$1.98M

Top Sells

1
+$6.28M
2
+$3.68M
3
+$1.6M
4
RVMD icon
Revolution Medicines
RVMD
+$1.59M
5
TSHA icon
Taysha Gene Therapies
TSHA
+$1.53M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
26
Zymeworks
ZYME
$1.39B
$815K 0.95%
68,459
+1,219
RARE icon
27
Ultragenyx Pharmaceutical
RARE
$3.14B
$771K 0.89%
21,290
+290
VERV
28
DELISTED
Verve Therapeutics
VERV
$744K 0.86%
162,724
+2,524
RCKT icon
29
Rocket Pharmaceuticals
RCKT
$400M
$556K 0.64%
83,350
-51,150
RAPP
30
Rapport Therapeutics
RAPP
$1.15B
$164K 0.19%
16,400
FBRX icon
31
Forte Biosciences
FBRX
$150M
$143K 0.17%
18,469
+330
ARTV
32
Artiva Biotherapeutics
ARTV
$147M
$136K 0.16%
45,456
+1,456
NUVB.WS icon
33
Nuvation Bio Inc Warrants
NUVB.WS
$64.4M
$17.5K 0.02%
90,832
ACLX icon
34
Arcellx
ACLX
$4.82B
– –
-10,743
CELC icon
35
Celcuity
CELC
$2.2B
– –
-25,000
CRNX icon
36
Crinetics Pharmaceuticals
CRNX
$3.91B
– –
-122,900
CRVS icon
37
Corvus Pharmaceuticals
CRVS
$525M
– –
-74,307
ELDN icon
38
Eledon Pharmaceuticals
ELDN
$206M
– –
-235,750
MRSN icon
39
Mersana Therapeutics
MRSN
$49.3M
– –
-44,820
NAMS icon
40
NewAmsterdam Pharma
NAMS
$4.1B
– –
-50,000
PCVX icon
41
Vaxcyte
PCVX
$5.5B
– –
-45,000
SGMO icon
42
Sangamo Therapeutics
SGMO
$193M
– –
-740,000
THRD
43
DELISTED
Third Harmonic Bio
THRD
– –
-49,800
TSHA icon
44
Taysha Gene Therapies
TSHA
$1.29B
– –
-884,244
TECX
45
Tectonic Therapeutic
TECX
$323M
– –
-33,008
1
2